Is Rosemary Sleep Quality Randomized Trial safe?

Updated August 2026

Quick Answer

Rosemary Sleep Quality Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Across studies, mobile interventions consistently improved user engagement, accessibility, and MH outcomes, including significant reductions in depression, anxiety, and stress symptoms ( p Conclusions mHealth applications substantially improve access to and delivery of MH services for AYPLHIV and related groups.

Key Takeaways

  • 01Across studies, mobile interventions consistently improved user engagement, accessibility, and MH outcomes, including significant reductions in depression, anxiety, and stress symptoms ( p Conclusions mHealth applications substantially improve access to and delivery of MH services for AYPLHIV and related groups. [Muleya C (2026)]
  • 02Background Mental health (MH) disorders remain a major global public health concern, disproportionately affecting adolescents and young people living with HIV (AYPLHIV). [Muleya C (2026)]
  • 03Limited access to MH services, stigma, and a shortage of trained professionals hinder effective care, particularly in low-resource settings. [Muleya C (2026)]
  • 04However, traditional sedative-hypnotic medications such as benzodiazepines, while effective, are often associated with dependency and adverse effects (;;). [Ma Dongchuan (2026)]
The current Migaku evidence database contains 2 reusable source documents for Rosemary Sleep Quality Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Across studies, mobile interventions consistently improved user engagement, accessibility, and MH outcomes, including significant reductions in depression, anxiety, and stress symptoms ( p Conclusions mHealth applications substantially improve access to and delivery of MH services for AYPLHIV and related groups. [Muleya C (2026); evidence level 1] - Background Mental health (MH) disorders remain a major global public health concern, disproportionately affecting adolescents and young people living with HIV (AYPLHIV). [Muleya C (2026); evidence level 1] - Limited access to MH services, stigma, and a shortage of trained professionals hinder effective care, particularly in low-resource settings. [Muleya C (2026); evidence level 1] - However, traditional sedative-hypnotic medications such as benzodiazepines, while effective, are often associated with dependency and adverse effects (;;). [Ma Dongchuan (2026); evidence level 3] - Frost et al., 2024 In summary, the prevalence of insomnia and its health implications prompt a reevaluation of the limitations associated with conventional pharmacotherapy. [Ma Dongchuan (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Mobile health applications for enhancing mental health access and outcomes among adolescents and young people living with HIV: a systematic review.
  2. Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review